MET—(-6%/AH)—reports 2Q20 results—the main negative in the quarter was not COVID-19 claims, but rather losses on private equity and derivative securities:
MetLife said it had higher COVID-related claims during the quarter, but did not provide specifics. The disease's effects in the third quarter would be largely offset by underwriting margins, the company said.
MetLife reported $710 million in net derivative losses, compared with $724 million in derivative gains a year ago.
That’s a $1.43B negative swing, YoY, but I can’t really complain insofar as MET gained $4.2B on derivatives during 1Q20 (#msg-155475813).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”